MedTrace Logo

Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter

NCT02872636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-08-13

No results posted yet for this study

Summary

The objective of this feasibility study is to demonstrate the safety and feasibility of using an investigational extracorporeal system and catheter to filter hemorrhagic cerebrospinal fluid (CSF) post subarachnoid hemorrhage (SAH) treatment, and reintroduce the CSF via the same catheter.

Conditions

  • Subarachnoid Hemorrhage

Interventions

DEVICE

Spinal catheter insertion with extracorporeal filtration of CSF

Extracorporeal filtration of CSF

Sponsors & Collaborators

  • Minnetronix

    lead INDUSTRY

Principal Investigators

  • Julie Messer · Minnetronix

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-23
Primary Completion
2018-04-16
Completion
2018-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02872636 on ClinicalTrials.gov